Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Debt Ratio (2016 - 2025)

Ptc Therapeutics has reported Debt Ratio over the past 14 years, most recently at 0.1 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.1 for Q4 2025, down 68.96% from a year ago — trailing twelve months through Dec 2025 was 0.1 (down 68.96% YoY), and the annual figure for FY2025 was 0.1, down 68.96%.
  • Debt Ratio for Q4 2025 was 0.1 at Ptc Therapeutics, down from 0.11 in the prior quarter.
  • Over the last five years, Debt Ratio for PTCT hit a ceiling of 0.54 in Q3 2023 and a floor of 0.1 in Q4 2025.
  • Median Debt Ratio over the past 5 years was 0.23 (2021), compared with a mean of 0.27.
  • Biggest five-year swings in Debt Ratio: skyrocketed 156.41% in 2023 and later plummeted 68.96% in 2025.
  • Ptc Therapeutics' Debt Ratio stood at 0.18 in 2021, then skyrocketed by 114.43% to 0.38 in 2022, then crashed by 33.13% to 0.25 in 2023, then rose by 26.22% to 0.32 in 2024, then plummeted by 68.96% to 0.1 in 2025.
  • The last three reported values for Debt Ratio were 0.1 (Q4 2025), 0.11 (Q3 2025), and 0.21 (Q2 2025) per Business Quant data.